In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia

ABSTRACT : Objective The aim of the present study was to evaluate the antifungal susceptibilities of isolates of Fusarium to amphotericin B, itraconazole and voriconazole. Methods The susceptibility of 44 isolates of Fusarium was tested by the E-test methodology. Results All the isolates were resist...

Full description

Autores:
Gaviria Rivera, Adelaida
Giraldo López, Alejandra
Cano Restrepo, Luz Elena
Tipo de recurso:
Article of investigation
Fecha de publicación:
2017
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/28671
Acceso en línea:
http://hdl.handle.net/10495/28671
Palabra clave:
Fusarium
Anfotericina B
Amphotericin B
Voriconazol
Voriconazole
Rights
openAccess
License
http://creativecommons.org/licenses/by/2.5/co/
id UDEA2_8c53041ab7846362e8306e17bfc0db5b
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/28671
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia
dc.title.alternative.spa.fl_str_mv Susceptibilidad antifúngica in vitro de aislamientos clínicos de Fusarium de Colombia
title In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia
spellingShingle In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia
Fusarium
Anfotericina B
Amphotericin B
Voriconazol
Voriconazole
title_short In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia
title_full In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia
title_fullStr In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia
title_full_unstemmed In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia
title_sort In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia
dc.creator.fl_str_mv Gaviria Rivera, Adelaida
Giraldo López, Alejandra
Cano Restrepo, Luz Elena
dc.contributor.author.none.fl_str_mv Gaviria Rivera, Adelaida
Giraldo López, Alejandra
Cano Restrepo, Luz Elena
dc.subject.decs.none.fl_str_mv Fusarium
Anfotericina B
Amphotericin B
Voriconazol
Voriconazole
topic Fusarium
Anfotericina B
Amphotericin B
Voriconazol
Voriconazole
description ABSTRACT : Objective The aim of the present study was to evaluate the antifungal susceptibilities of isolates of Fusarium to amphotericin B, itraconazole and voriconazole. Methods The susceptibility of 44 isolates of Fusarium was tested by the E-test methodology. Results All the isolates were resistant to itraconazole, and 89 % and 54,5 % were resistant to amphotericin B and voriconazole, respectively. Discussion The results confirm the high level of resistance reported, regardless of the species or the strain of Fusarium involved. The high MICs level observed are worrying and suggest that new drugs are needed.
publishDate 2017
dc.date.issued.none.fl_str_mv 2017
dc.date.accessioned.none.fl_str_mv 2022-05-26T13:19:08Z
dc.date.available.none.fl_str_mv 2022-05-26T13:19:08Z
dc.type.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.local.spa.fl_str_mv Artículo de investigación
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia Gaviria-Rivera,Adelaida Maria et al. Revista de Salud Pública(2017),19(6):800 http://dx.doi.org/10.15446/rsap.v19n6.54654
dc.identifier.issn.none.fl_str_mv 0124-0064
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10495/28671
dc.identifier.doi.none.fl_str_mv 10.15446/rsap.v19n6.54654
dc.identifier.eissn.none.fl_str_mv 2539-3596
identifier_str_mv In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia Gaviria-Rivera,Adelaida Maria et al. Revista de Salud Pública(2017),19(6):800 http://dx.doi.org/10.15446/rsap.v19n6.54654
0124-0064
10.15446/rsap.v19n6.54654
2539-3596
url http://hdl.handle.net/10495/28671
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Rev. Salud Pública.
dc.rights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by/2.5/co/
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/2.5/co/
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.format.extent.spa.fl_str_mv 6
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Universidad Nacional de Colombia, Facultad de Medicina, Instituto de Salud Pública
dc.publisher.group.spa.fl_str_mv Micología Médica y Experimental
dc.publisher.place.spa.fl_str_mv Bogotá, Colombia
institution Universidad de Antioquia
bitstream.url.fl_str_mv http://bibliotecadigital.udea.edu.co/bitstream/10495/28671/1/CanoLuz_2017_InvitroClinicalIsolates.pdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/28671/2/license_rdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/28671/3/license.txt
bitstream.checksum.fl_str_mv 876e0bd445fbbc60ecd71a4561a6fdaf
1646d1f6b96dbbbc38035efc9239ac9c
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1812173093125226496
spelling Gaviria Rivera, AdelaidaGiraldo López, AlejandraCano Restrepo, Luz Elena2022-05-26T13:19:08Z2022-05-26T13:19:08Z2017In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia Gaviria-Rivera,Adelaida Maria et al. Revista de Salud Pública(2017),19(6):800 http://dx.doi.org/10.15446/rsap.v19n6.546540124-0064http://hdl.handle.net/10495/2867110.15446/rsap.v19n6.546542539-3596ABSTRACT : Objective The aim of the present study was to evaluate the antifungal susceptibilities of isolates of Fusarium to amphotericin B, itraconazole and voriconazole. Methods The susceptibility of 44 isolates of Fusarium was tested by the E-test methodology. Results All the isolates were resistant to itraconazole, and 89 % and 54,5 % were resistant to amphotericin B and voriconazole, respectively. Discussion The results confirm the high level of resistance reported, regardless of the species or the strain of Fusarium involved. The high MICs level observed are worrying and suggest that new drugs are needed.RESUMEN : Objetivo Evaluar la susceptibilidad antifúngica in vitro de aislamientos de Fusarium a los antimicóticos amfotericina B, itraconazol y voriconazol. Métodos La susceptibilidad de 44 aislamientos clínicos de Fusarium fue evaluada por el método de difusión en disco, E-test. Resultados Todos los aislamientos fueron resistentes al itraconazol, y 89 % y 54,5 % fueron resistentes a la amfotericina B y al voriconazol, respectivamente. Discusión Los resultados confirman el alto nivel de resistencia reportado, independiente de la especie o la cepa de Fusarium involucrada. Los valores tan altos de MICs son preocupantes y sugieren la necesidad de evaluar nuevos medicamentos.COL00137096application/pdfengUniversidad Nacional de Colombia, Facultad de Medicina, Instituto de Salud PúblicaMicología Médica y ExperimentalBogotá, Colombiainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by/4.0/In vitro antifungal susceptibility of clinical isolates of Fusarium from ColombiaSusceptibilidad antifúngica in vitro de aislamientos clínicos de Fusarium de ColombiaFusariumAnfotericina BAmphotericin BVoriconazolVoriconazoleRev. Salud Pública.Revista de Salud Pública800805196ORIGINALCanoLuz_2017_InvitroClinicalIsolates.pdfCanoLuz_2017_InvitroClinicalIsolates.pdfArtículo de investigaciónapplication/pdf337682http://bibliotecadigital.udea.edu.co/bitstream/10495/28671/1/CanoLuz_2017_InvitroClinicalIsolates.pdf876e0bd445fbbc60ecd71a4561a6fdafMD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8927http://bibliotecadigital.udea.edu.co/bitstream/10495/28671/2/license_rdf1646d1f6b96dbbbc38035efc9239ac9cMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://bibliotecadigital.udea.edu.co/bitstream/10495/28671/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/28671oai:bibliotecadigital.udea.edu.co:10495/286712022-05-26 08:19:09.187Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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